Order Article Reprints

Trommer M, Adams A, Celik E, Fan J, Funken D, Herter JM, Linde P, Morgenthaler J, Wegen S, Mauch C, et al. Oncologic Outcome and Immune Responses of Radiotherapy with Anti-PD-1 Treatment for Brain Metastases Regarding Timing and Benefiting Subgroups. Cancers. 2022; 14(5):1240. https://doi.org/10.3390/cancers14051240

Trommer, Maike, Anne Adams, Eren Celik, Jiaqi Fan, Dominik Funken, Jan M. Herter, Philipp Linde, Janis Morgenthaler, Simone Wegen, Cornelia Mauch, and et al. 2022. "Oncologic Outcome and Immune Responses of Radiotherapy with Anti-PD-1 Treatment for Brain Metastases Regarding Timing and Benefiting Subgroups" Cancers 14, no. 5: 1240. https://doi.org/10.3390/cancers14051240

Trommer, M., Adams, A., Celik, E., Fan, J., Funken, D., Herter, J. M., Linde, P., Morgenthaler, J., Wegen, S., Mauch, C., Franklin, C., Galldiks, N., Werner, J.-M., Kocher, M., Rueß, D., Ruge, M., Meißner, A.-K., Baues, C., & Marnitz, S. (2022). Oncologic Outcome and Immune Responses of Radiotherapy with Anti-PD-1 Treatment for Brain Metastases Regarding Timing and Benefiting Subgroups. Cancers, 14(5), 1240. https://doi.org/10.3390/cancers14051240